Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Daisuke Kobayashi Last modified date:2021.06.25

Graduate School
Undergraduate School
Other Organization

E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
 Reseacher Profiling Tool Kyushu University Pure
Academic Degree
Country of degree conferring institution (Overseas)
Field of Specialization
Clinical pharmacy
Total Priod of education and research career in the foreign country
Outline Activities
Research on the effects of genetic polymorphisms on efficacy and adverse reactions of drugs
Research Interests
  • Reserch for inter-invidiual differences in the pharmacodynamics and pharmacokinetics of clinically useful drugs
    keyword : antidepressants, pharmacogenetics
  • Study on establishment of simultaneous measurement method and administration design method of blood drug concentration of antiepileptic drug
    keyword : Antiepileptic drug, TDM
  • Research for drug transporters
    keyword : drug transporters, genetic polymorphism
  • Development of learning strategy of clinical pharmacy for pharmacy students
    keyword : clinical pharmacy, education
Academic Activities
1. Sasaki T, Hirota T, Ryokai Y, Kobayashi D, Kimura M, Irie S, Higuchi S, Ieiri I., Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.

, Drug Metab Pharmacokinet., published online; April 22, 2011., 2011.04.
2. Murata Y, Kobayashi D, Imuta N, Haraguchi K, Ieiri I, Nishimura R, Koyama S, Mine K., Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome., J Clin Psychopharmacol., 30, 1, 11-7, 2010.02.
3. Tanaka M, Kobayashi D, Murakami Y, Ozaki N, Suzuki T, Iwata N, Haraguchi K, Ieiri I, Kinukawa N, Hosoi M, Ohtani H, Sawada Y, Mine K. , Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea., Int J Neuropsychopharmacol., 11(2):261-7., 2008.03.
4. Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, Suzuki H, Nanba E, Oshimura M, Terakawa N, Otsubo K, Mine K, Sugiyama Y, Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta, Drug Metab Dispos, 10.1124/dmd.104.001628, 33, 1, 94-101, 2005; 33(1):94-101, 2005.01.
5. Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, Kobayashi D, Ieiri I, Mine K, Ohtsubo K, Sugiyama Y, Functional analysis of SNPs variants of BCRP/ABCG2, Pharm Res, 10.1023/B:PHAM.0000045245.21637.d4, 21, 10, 1895-1903, 2004; 21(10):1895-903, 2004.10.
6. Takane H, Kobayashi D, Hirota T, Kigawa J, Terakawa N, Otsubo K, Ieiri I, Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene, J Pharmacol Exp Ther, 10.1124/jpet.104.069724, 311, 3, 1179-1187, 2004; 311(3):1179-87, 2004.12.
Membership in Academic Society
  • The Japanese Society of Therapeutic Drug Monitoring
  • The Pharmaceutical Society of Japan
  • Japanese Society of Pharmaceutical Health Care and Sciences
  • The Japanese Society for the Study of Xenobiotics
  • International Association of Therapeutic Drug Monitoring and Clinical Toxicology